Ingmar Hoerr
- Immunology top 2%
- Immunotherapy and Immune Responses 10
- Immune Cell Function and Interaction 4
- Infectious Diseases top 5%
- Viral gastroenteritis research and epidemiology 2
- Molecular Biology top 5%
- RNA Interference and Gene Delivery 11
- DNA and Nucleic Acid Chemistry 2
- Genetics top 5%
- Virus-based gene therapy research 2
- Animal Science and Zoology top 5%
-
- CAR-T cell therapy research 3
-
- Bacteriophages and microbial interactions 2
- Co-authors
- Steve PascoloBirgit ScheelGünther JungHans‐Georg RammenseeJochen ProbstBenjamin WeideReinhard ObstJean‐Philippe Carralot
- Journals
- European Journal of Immunology (4 papers)OncoImmunology (2 papers)Cellular and Molecular Life Sciences (2 papers)
- Partner nations
- GermanySwitzerlandItaly
In The Last Decade
Ingmar Hoerr
18 papers receiving 2.2k citations
Hit Papers
Peers
Comparison fields: 5 of 79
- Immunology 1.2k
- Infectious Diseases 527
- Molecular Biology 1.7k
- Genetics 526
- Animal Science and Zoology 143
Countries citing papers authored by Ingmar Hoerr
This map shows the geographic impact of Ingmar Hoerr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ingmar Hoerr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ingmar Hoerr more than expected).
Fields of papers citing papers by Ingmar Hoerr
This network shows the impact of papers produced by Ingmar Hoerr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ingmar Hoerr. The network helps show where Ingmar Hoerr may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ingmar Hoerr, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 5 | |
| 2 | Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: an open-label, non-randomised, prospective, first-in-human phase 1 clinical trialbreakdown → | 2017 | 373 |
| 3 | 2017 | 2 | |
| 4 | 2016 | 18 | |
| 5 | 2015 | 211 | |
| 6 | 2015 | 48 | |
| 7 | 2010 | 178 | |
| 8 | 2009 | 297 | |
| 9 | 2008 | 203 | |
| 10 | 2007 | 168 | |
| 11 | 2006 | 93 | |
| 12 | 2006 | 64 | |
| 13 | 2005 | 168 | |
| 14 | 2005 | 20 | |
| 15 | 2005 | 28 | |
| 16 | 2004 | 113 | |
| 17 | 2000 | 4 | |
| 18 | 2000 | 297 |
About Ingmar Hoerr
Ingmar Hoerr is a scholar working on Immunology, Molecular Biology and Virology, having authored 18 papers that have together received 2.3k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (11 papers), Immunotherapy and Immune Responses (10 papers), Immune Cell Function and Interaction (4 papers), CAR-T cell therapy research (3 papers), Viral gastroenteritis research and epidemiology (2 papers), Virus-based gene therapy research (2 papers), Bacteriophages and microbial interactions (2 papers) and DNA and Nucleic Acid Chemistry (2 papers). The work is most often cited by research in Immunology (1.2k citations), Infectious Diseases (527 citations) and Molecular Biology (1.7k citations). Ingmar Hoerr has collaborated with scholars based in Germany, Switzerland and Italy. Frequent co-authors include Steve Pascolo, Birgit Scheel, Günther Jung, Hans‐Georg Rammensee, Jochen Probst, Hans‐Georg Rammensee, Benjamin Weide, Reinhard Obst, Jean‐Philippe Carralot and Claus Garbe. Their work appears in journals such as European Journal of Immunology, OncoImmunology, Cellular and Molecular Life Sciences, Journal of Immunotherapy and Molecular Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.